The short answer
Selling a med spa runs through nine stages: preparation, valuation, a blind approach to a curated buyer list, non-disclosure agreements and an information memorandum, indications of interest, management meetings, a letter of intent, confirmatory diligence, and closing. Most sales take six to twelve months. Most of the price, however, is decided before a buyer is ever contacted.
Quick answers
Seven narrow questions, one sentence each. These catch conversational queries that don’t warrant reading the article. Phrased deliberately differently from the FAQ at the bottom, and not included in the FAQPage schema — two Question entities sharing a name but not an answer is a quality problem.
What is the first step in selling a med spa? Preparation — cleaning the financials and reducing how much the practice depends on you, both of which take longer than the sale itself.
Can I sell a med spa quickly? Rarely well; six to twelve months is normal, and the compressed sales are usually the ones negotiated with a single buyer.
Who actually buys med spas? Individual operators, independent sponsors, regional groups, sponsor-backed platforms making tuck-in acquisitions, and institutional buyers acquiring platforms outright.
Do I have to tell my staff? Not until you choose to; a properly run process keeps the practice unnamed until a buyer has signed a non-disclosure agreement.
What is the point of no return? The letter of intent — it is largely non-binding on price and firmly binding on exclusivity.
Can I sell without a broker or advisor? Yes, and it works best where the buyer is already known to you and the practice is small and straightforward.
Should I respond to an unsolicited offer? Replying costs nothing; discussing numbers before you have an independent view of value costs a great deal.
Key takeaways
- A med spa sale runs through nine identifiable stages, and the leverage sits almost entirely in the first five.
- Six to twelve months is the normal timeline, with roughly nine months a fair baseline for a well-run process.
- The letter of intent is the threshold, not the milestone — signing it switches off the competitive tension you spent months building.
- More than 90 percent of US med spas remain independently owned, which is why acquirers are competing rather than picking through what is left.
- Compliance and corporate structure now stall more med spa transactions than they did two years ago, and they are cheaper to fix eighteen months out than during exclusivity.
Before you start: three questions worth answering honestly
Owners arrive at this decision through one of three doors — an unsolicited approach, exhaustion, or a growth plan that needs capital they would rather not borrow. The door you came through shapes the answer, so it is worth being honest about which one it was.
None of these questions needs a final answer today. Each needs enough of an answer that you can recognise a good outcome when one is in front of you.
Are you selling the practice, or selling your job?
If you personally deliver most of the treatments, a buyer is acquiring a business that partly walks out of the door with you.
That does not prevent a sale. Single-provider practices transact regularly. But it changes both the price and the structure, usually toward an earnout — meaning a portion of the consideration depends on results achieved after you have stopped being the reason patients book.
Do you want out, or do you want a partner?
These lead to different processes, different buyers, and different lives.
A full exit means an outright sale and a defined transition period. A partnership means retaining a stake, taking capital, accepting governance, and continuing to run the practice inside somebody else’s structure.
Owners who have not decided tend to end up with whichever one the first interested buyer prefers. That is not a decision; it is a default.
What number makes this worth doing?
Not an aspirational number. A number that, after transaction costs, debt repayment, escrow and tax, changes your circumstances in the way you actually want them changed.
Without it, you cannot distinguish a good offer from a flattering one — and by month eight of a process you will be tired, invested, and inclined to accept.
How long does it take to sell a med spa?
Most med spa sales take six to twelve months from engagement to close, with around nine months a fair baseline for a well-run process. Confirmatory diligence after the letter of intent typically accounts for 45 to 90 days of that. Preparation before going to market sits on top, and disorganised financial records extend everything.
What the published guidance says
The advisory guidance clusters tightly, which is unusual in this sector and worth noting.
Skytale Group describes a going-to-market timeline of roughly six to nine months, with front-end preparation measured in weeks or months on top of that, and post-letter-of-intent diligence running 45 to 90 days. Practice Transitions Group, Aesthetic Brokers, Triumphant Partners and Auxo Capital Advisors describe end-to-end timelines of six to twelve months, with nine months as the well-run-process baseline.
Triumphant Partners makes an additional observation worth sitting with: sellers who organise financials and address compliance gaps early tend to close faster.
What actually stretches a timeline
Three things, and all three are decided before you begin:
- Books that need reconstruction rather than verification. If a quality of earnings review has to rebuild your financials, the buyer’s confidence falls at the same rate as the clock runs.
- Lease uncertainty. A short remaining term, an unclear assignment clause, or a personal guarantee becomes a negotiation inside the negotiation.
- Compliance documents that do not match how the practice actually operates. Medical director agreements, supervision records, corporate structure. This is the section further down the page.
Notice that none of them is the buyer.
The single largest variable in how long your sale takes is how ready you were on the day you started. That is an unglamorous conclusion, and it is the most useful one in this article.
What are the nine stages of a med spa sale?
A med spa sale runs through nine stages: preparation, valuation and positioning, a blind teaser to a curated buyer list, non-disclosure agreements and the information memorandum, indications of interest, management meetings, the letter of intent, confirmatory diligence, and the definitive agreement. Leverage is highest in the first five and falls sharply at the seventh.
Stages 1 to 3 — before a buyer knows your name
1. Preparation. Everything that happens before anybody outside the practice is aware. Financial cleanup, documenting add-backs with invoices and bank records, tightening provider agreements, organising leases and licences, and reducing the share of revenue that depends on you personally.
This stage produces more value per hour than any other, and it is the one owners skip. Twelve to twenty-four months of deliberate preparation routinely moves the multiple further than any negotiating tactic available later.
2. Valuation and positioning. Establish adjusted earnings, then a defensible range. Decide which buyer type the practice suits. A single-location practice with one injector and a strong local brand is a different product from a three-location group with a management layer, and they are marketed to different people.
3. The teaser and the buyer list. The teaser is a one-page summary describing the business without identifying it — region rather than address, revenue band rather than exact figures, service mix, growth trajectory. It goes to a curated list of qualified buyers, not to a public listing site.
The list matters more than the document. Eight genuinely qualified acquirers produce a better outcome than eighty who cannot fund a transaction.
Stages 4 to 6 — the market process
4. Non-disclosure and the information memorandum. Buyers who want more sign an NDA. Only then do they receive the confidential information memorandum — financials, patient metrics, provider detail, service mix, membership base, growth plan.
This is your practice’s case for itself, and everything in it will be tested in diligence. Anything that does not survive testing costs you credibility at exactly the point where credibility is worth money.
5. Indications of interest. Buyers submit a non-binding indication by a set deadline: a valuation range, a proposed structure, and how they would fund it.
Non-binding matters. An indication of interest is an opening position, not a commitment. The deadline is the mechanism — multiple parties responding to the same date creates the competitive tension that a sequence of one-at-a-time conversations cannot.
6. Management meetings. Shortlisted buyers meet you, usually off-site or outside operating hours. They are testing whether the numbers match the person, whether the team is real, and whether the culture survives their ownership.
Owners often experience this as an interrogation. It is closer to mutual assessment — you are also deciding who you would be willing to hand your staff to.
Stages 7 to 9 — from letter of intent to closing
7. The letter of intent. The chosen buyer sets out price, structure, an exclusivity period, and the outline of everything else.
This is the most consequential document in the process. Price and structure are largely non-binding. Exclusivity is binding, and exclusivity is the point — once you sign, you stop talking to everybody else, and the competitive process you spent months assembling switches off by agreement.
Terms that are straightforward to negotiate before the letter of intent become very difficult afterwards. Exclusivity length, the earnout metric and its definition, escrow size and duration, the working capital peg methodology, rollover terms, non-compete scope, and what happens if diligence produces a price reduction — all of it is cheaper on the near side of that signature.
8. Confirmatory diligence. Typically 45 to 90 days. A quality of earnings review examines adjusted earnings line by line. Legal diligence examines contracts, corporate structure, compliance and litigation. Operational diligence examines provider retention, patient data and systems.
Deals that fail usually fail here, and usually because something in the information memorandum did not survive contact with evidence.
9. Definitive agreement and closing. Lawyers negotiate the purchase agreement, disclosure schedules, escrow and indemnities. Then funds move and ownership transfers. Expect several weeks of detailed drafting that feels slower than it ought to.
Who buys med spas — and what does each type want?
Five buyer types acquire med spas: individual operators, independent sponsors and search funds, regional strategic groups, sponsor-backed platforms making tuck-in acquisitions, and institutional buyers acquiring platforms outright. They want different practices, at different prices, for different reasons.
The market context explains why any of them are contacting you. American Med Spa Association industry data puts private-equity consolidation at roughly 3 to 4 percent of US med spas, with more than 90 percent still independently owned, against a segment AmSpa’s 2024 State of the Industry Report counted at approximately 10,488 locations and over $17 billion in revenue.
In most healthcare verticals that window closed years ago. Medical aesthetics is early, which is why buyers are competing for quality independent practices rather than picking through what remains.
The five types
| Buyer type | Typically acquires | Pays | You, afterwards |
|---|---|---|---|
| Individual operator | Single location, owner-operated | Lowest, often on SDE, sometimes with seller financing | Fully out after a short handover |
| Independent sponsor or search fund | Roughly $500K–$3M of earnings | Bank debt plus equity co-invest | Out, or a short consulting period |
| Regional strategic group | Practices adjacent to their footprint | Mid-range, cash-heavy | Short transition, sometimes a role |
| Sponsor-backed platform, tuck-in | Roughly $1M–$5M adjusted EBITDA | Mid to high, structured | Defined role, integrated, often rollover |
| Institutional platform buyer | $10M+ adjusted EBITDA | Highest, most conditions | Significant continuing involvement |
One practical note on independent sponsors: they expanded into medical aesthetics through the current cycle, which means more inbound approaches now come from buyers who do not yet have committed capital. It is a fair and unembarrassing question to ask early — is your funding committed, or are you raising it if we agree terms?
Why the highest number is not automatically the best deal
A platform offer at a higher multiple with a substantial rollover component and a two-year earnout is a fundamentally different proposition from a lower all-cash offer.
Not worse. Different — different risk, different timeline, and a different next three years of your life.
The comparison that matters is net proceeds under a downside case, not the headline multiple. Model each offer twice: once assuming the contingent consideration pays in full, and once assuming it pays nothing. If the second number does not work for you, the offer does not work for you.
What will a buyer examine in due diligence?
Diligence is not a formality. It is a systematic search for reasons to pay less, conducted by people who do this professionally against an owner who is doing it once. Assume every figure you present will be independently verified.
Financial
Three years of profit and loss statements, balance sheets, tax returns, monthly management accounts, and documentary support for every add-back. A quality of earnings review is standard above roughly $1 million of adjusted EBITDA.
Revenue quality
Service mix, revenue per provider, membership base and churn, prepaid package liabilities, patient retention, and how concentrated revenue is by provider and by service line.
Prepaid and deferred balances deserve particular attention in medical aesthetics. Package revenue collected in advance represents an obligation to deliver treatment later, and buyers treat the unredeemed portion as a liability to be funded at closing — whether or not your balance sheet presents it that way.
People
Provider agreements, tenure, compensation, restrictive covenants, and whether key injectors are contractually secured through the transition. A tenured bench under agreement shortens diligence as well as raising the price.
Compliance and structure
Medical director agreements, supervision and delegation documentation, scope-of-practice records, corporate structure, and marketing claims — including influencer arrangements and advertising disclosures. This is the section immediately below.
Assets and obligations
Device inventory, remaining useful life, utilisation, outstanding device finance, lease terms and assignment rights, and product purchasing records against authorised distributor channels.
The uncomfortable pattern across all five: most price reductions after a letter of intent are not the buyer being aggressive. They are the buyer finding something the seller already knew about and had not disclosed. Disclosing early is almost always cheaper than being discovered.
Why compliance now decides more med spa deals than it used to
Corporate practice of medicine doctrine restricts non-physician ownership and control of medical practices in a majority of states, which shapes how med spa transactions must be structured. That has always been true. What changed is enforcement, and what changed with it is how deeply buyers examine structure before committing.
What changed
CPOM doctrine prohibits unlicensed entities from owning or controlling medical practices in most states — the reason management services organisation structures exist at all, with an MSO providing administrative support to a physician-owned professional corporation. The American Bar Association’s Health Law Section identifies CPOM restrictions in more than 30 states.
California then went further. SB 351 was signed in October 2025 and took effect on 1 January 2026, making California the second state to directly regulate private equity and hedge fund involvement in physician and dental practices. It prohibits those investors from interfering with professional clinical judgment and restricts management companies from participating in billing, coding, equipment selection and clinical staff oversight. A companion law, AB 1415, extended transaction reporting obligations.
Enforcement followed quickly. The California Attorney General settled with Aspen Dental in May 2026 over alleged corporate practice of dentistry violations — $2 million in penalties, $300,000 in restitution, and injunctive terms — and announced a further settlement with Carbon Health in June 2026, reported as the first resolution directly targeting an MSO-PC structure under the doctrine.
What it means if you are preparing to sell
Three practical consequences:
- Structural diligence goes deeper, and management services agreements drafted before 2025 may need amendment. The requirements generally apply to arrangements that continue to operate, not only to new ones.
- Timelines lengthen in affected states.
- Clean documentation is now a differentiator. A practice with a current medical director agreement, documented supervision, clear delegation protocols and a defensible corporate structure is materially more attractive than one without — because the buyer inherits the risk, and a buyer who inherits risk prices it.
Compliance is not the interesting part of selling a practice. It is increasingly the part that determines whether the sale completes.
Regulation varies by state and changes. This is background, not legal advice — take advice on your own structure.
How is confidentiality actually maintained?
Confidentiality is designed rather than hoped for. It rests on a blind teaser that does not identify the practice, non-disclosure agreements signed before any detailed information is shared, meetings held away from the premises, and an internal circle kept deliberately small.
Owners worry about this more than anything else in the process, and they are right to. A leak has consequences before there is any deal to justify them: injectors update their résumés, competitors approach your staff, patients ask questions at the front desk.
The controls that work
- Nothing that identifies the practice leaves your hands before an NDA is signed.
- No public listing on marketplace sites — which is where confidentiality most often fails.
- Management meetings off-site or outside operating hours.
- Diligence documents in a controlled data room with access logs, never over email.
- An internal circle of one or two people, if any, before the letter of intent.
The tension nobody resolves cleanly
There is a genuine conflict here, and it is worth naming rather than smoothing over.
Your longest-serving injector will feel differently about learning late. That person’s retention may also be a condition of the deal. Telling them early risks the leak; telling them late risks the relationship.
There is no clean answer — only a judgement about timing. Most advisors favour informing key people once the outcome is close to certain rather than while it is still speculative, and most owners find that easier to justify afterwards than to feel comfortable with at the time.
What happens to your staff and your patients?
Most owners rank this near price. Some rank it above.
Staff. Buyers usually want the team to stay — the providers are much of what is being purchased. Employment continuity is standard, though compensation structures and benefits are frequently harmonised to the acquirer’s model afterwards. That harmonisation is worth asking about specifically, and early, because it is easier to negotiate before a letter of intent than to discover after one. Retention arrangements for key providers can form part of the deal.
Patients. Continuity of care is in the buyer’s interest. Records transfer under applicable privacy rules, and communication is normally coordinated so that patients receive a considered message rather than a rumour.
Your brand. Ask early whether the practice keeps its name. Some platforms preserve local brands deliberately; others rebrand within a year. Neither approach is wrong, but owners who assumed one and got the other tend to describe the sale as a disappointment regardless of the price they received.
All three of these are negotiable, and they are negotiable before the letter of intent. Afterwards they become requests.
Do you need an M&A advisor to sell a med spa?
There is no legal requirement to use an advisor. The practical argument is competitive tension: a single-buyer negotiation hands the buyer control of price, pace and terms, while a structured process with several qualified buyers working to the same deadlines changes that balance. The question is whether the fee is smaller than the value the process creates.
The case for selling without one
It can work — where the buyer is already known to you, the practice is small and straightforward, and the price is modest. You keep the fee.
You also do the work: the buyer list, the information memorandum, the data room, the diligence responses, and the negotiation, during the months you are still running a practice full-time. That cost is real even though it does not appear on an invoice.
The case for representation
Mainly leverage and reach. An advisor brings a buyer list you do not have, runs the process to deadlines that create competition, manages diligence so you can keep operating, and — often the most valuable part — knows which letter-of-intent terms are standard and which are being tested on you because you are new to this.
What to check before engaging anyone
Two things, and the first matters more than owners expect.
Sector experience. Ask how many medical aesthetics transactions they have completed, specifically. CPOM structure, injectable supervision, membership revenue accounting and device economics are all places a capable generalist can miss something expensive.
Fee structure. How it is calculated, what triggers it, what happens if the process does not complete, and whether there is a tail period after termination.
When should you start? A 24-month view
The most profitable work happens long before a buyer appears.
| Period | Focus |
|---|---|
| 24–18 months out | Financial cleanup. Separate personal expenses. Begin documenting add-backs contemporaneously rather than reconstructing them later. |
| 18–12 months out | Reduce owner dependency. Build the provider bench, transfer patient relationships deliberately, document protocols. Grow recurring membership revenue. |
| 12–6 months out | Compliance review — medical director agreement, supervision records, corporate structure. Resolve lease and device finance questions. |
| 6–3 months out | Engage an advisor. Establish a valuation range. Prepare the information memorandum and assemble the data room. |
| Go to market | Six to twelve months from launch to close. |
An owner who begins two years out and one who begins the week after an unsolicited email arrives receive materially different offers for the same practice.
That gap is the return on preparation. It is also the single most controllable variable in the entire process, which is why this article ends here rather than with a negotiating tip.
Frequently asked questions
How do I sell my med spa? Through nine stages: preparation, valuation, a blind teaser to a curated buyer list, non-disclosure agreements and an information memorandum, indications of interest, management meetings, a letter of intent, confirmatory diligence, and closing. Most of the value is determined before a buyer is contacted.
How long does it take to sell a med spa? Six to twelve months from engagement to close is normal, with around nine months a fair baseline. Confirmatory diligence after the letter of intent typically accounts for 45 to 90 days. Disorganised financial records extend it considerably.
How much can I sell my med spa for? On a multiple of adjusted earnings rather than revenue. Published 2026 sources place single-location practices at roughly 4x to 7x adjusted EBITDA and multi-location groups at 6x to 9x. Owner-operated practices are usually priced on seller discretionary earnings instead.
Should I accept an unsolicited offer for my med spa? Not without testing it. An unsolicited approach means a buyer decided your practice was worth acquiring before you decided to sell, which is a strong position for them. Establish an independent view of value before discussing numbers.
Can I sell my med spa without a broker? Yes. The trade-off is competitive tension — a single-buyer negotiation gives the buyer control of price and pace, and you manage diligence yourself while continuing to operate. It works best for smaller, straightforward practices where the buyer is already known to you.
When is the best time to sell a med spa? Buyers pay most for two to three years of consistent growth, clean financials and low owner dependency, which usually means selling from strength rather than from exhaustion. Practices sold reactively, during a decline or after an owner has disengaged, price at the bottom of the range.
Will my staff find out I am selling? Not from a properly run process — the practice stays unnamed until a buyer signs a non-disclosure agreement. Most owners tell a small internal circle before the letter of intent and inform the wider team close to closing, when the outcome is certain rather than speculative.
